Industrial Goods » Machinery | Galaxy Biomedical Investment Co. Ltd.

Galaxy Biomedical Investment Co. Ltd. A | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
780
798
827
1,194
1,032
749
Cost of Goods Sold (COGS) incl. D&A
592
615
639
910
780
630
Gross Income
189
183
188
285
252
119
SG&A Expense
161
171
188
231
261
694
EBIT
-
28
12
61
9
610
Unusual Expense
-
30
30
20
19
64
Non Operating Income/Expense
35
99
134
6
21
32
Interest Expense
52
62
21
11
16
66
Pretax Income
20
31
130
38
17
692
Income Tax
9
10
36
20
4
39
Equity in Affiliates
2
2
8
2
7
5
Consolidated Net Income
12
23
103
16
15
736
Net Income
12
26
103
13
10
706
Net Income After Extraordinaries
12
26
103
13
10
706
Net Income Available to Common
12
26
103
13
10
706
EPS (Basic)
0.02
0.04
0.10
0.01
0.01
0.64
Basic Shares Outstanding
699
699
1,000
1,100
1,100
1,100
EPS (Diluted)
0.02
0.04
0.10
0.01
0.01
0.64
Diluted Shares Outstanding
699
699
1,000
1,100
1,100
1,100
EBITDA
74
60
58
102
37
563
Other Operating Expense
-
-
-
8
-
36
Non-Operating Interest Income
-
1
7
8
3
13
Minority Interest Expense
-
3
3
4
4
30

About Galaxy Biomedical Investment Co.

View Profile
Address
Galaxy Software Technology Park
Beihai Guangzi Zhuang 536000
China
Employees -
Website http://www.g-biomed.com
Updated 07/08/2019
Galaxy Biomedical Investment Co., Ltd. engages in the provision of investment in bio-pharmaceutical industry, transmission and distribution system industry, and electronic information industry. The company focuses on biotechnology and build its pharmaceutical and medical service industry structure; production and sale of transformer products; and manufacture of resistors, sensors, brake resistor box, radio frequency components, and potentiometers. The company was founded on June 20, 1993 and is headquartered in Beihai, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.